Summary
The effects of noradrenaline, its five metabolites and metanephrine, were studied on tyrosine hydroxylase activity in guinea-pig atria. The deaminated metabolite, (±)-3,4-dihydroxyphenylglycol (DOPEG), was equipotent with (±)-noradrenaline in its inhibitory action on tyrosine hydroxylase activity in the homogenates of guinea-pig atria. The inhibition by DOPEG was competitive with the cofactor, reduced pteridine. The deaminated acid, 3,4-dihydroxymandelic acid (DOMA) and the O-methylated deaminated acid, 3-methoxy, 4-hydroxymandelic acid (VMA) had 1/50th and 1/30th, respectively, the potency of noradrenaline in inhibiting tyrosine hydroxylase. The rest of the metabolites did not inhibit tyrosine hydroxylase in homogenates in concentrations up to 1.0 mM. In intact guinea-pig atria noradrenaline was considerably more potent than DOPEG in inhibiting tyrosine hydroxylase. Normetanephrine 1.4×10−4 M inhibited tyrosine hydroxylase in the intact tissue but failed to inhibited the enzyme in the homogenate even in higher concentrations. The effect of normetanephrine in the intact tissue is related to the ability of this compound to release endogenous noradrenaline.
A reserpine-like agent, Ro 4-1284, did not inhibit tyrosine hydroxylase activity in the homogenate but in the intact tissue the inhibition was more than 50%. This effect of Ro 4-1284 in the intact tissue appears to be related to the releasing effects of this agent and to an increase in the axoplasmic levels of DOPEG.
Since the formation of the deaminated glycol, DOPEG, represents the main metabolic pathway for the neurotransmitter in adrenergic nerve endings, the present results are compatible with the view that, in addition to the pool of extravesicular noradrenaline, the cytoplasmic concentration of DOPEG could also participate in the regulation of the activity of tyrosine hydroxylase.
Similar content being viewed by others
References
Adler-Graschinsky, E., Langer, S. Z., Rubio, M. C.: Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria. J. Pharmacol. exp. Ther. 180, 286–301 (1972)
Alousi, A., Weiner, N.: The regulation of norepinephrine synthesis in sympathetic nerves: effects of nerve stimulation, cocaine and catecholamine releasing agents. Proc. nat. Acad. Sci. (Wash.) 56, 1491–1496 (1966)
Dubocovich, M., Langer, S. Z.: Effects of flow-stop on the metabolism of noradrenaline released by nerve stimulation in the perfused spleen. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 179–194 (1973)
Fellman, J. H.: Purification and properties of adrenal l-dopa decarboxylase. Enzymologia 20, 366–376 (1959)
Graefe, K. H., Stefano, F. J. E., Langer, S. Z.: Preferential metabolism of (−)-3H-norpinephrine through the deaminated glycol in the rat vas deferens. Biochem. Pharmacol. 22, 1147–1160 (1973)
Kopin, I. J., Weise, V. K., Sedvall, G. C.: Effect of false transmitter on norepinephrine synthesis. J. Pharmacol. exp. Ther. 170, 246–252 (1969)
Langer, S. Z.: The metabolism of 3H-noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat. J. Physiol. (Lond.) 208, 515–546 (1970)
Langer, S. Z., Rubio, M. C.: Effect of the noradrenaline metabolites on the adrenergic receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 276, 71–88 (1973)
Langer, S. Z., Stefano, F. J. E., Enero María A.: Pre- and postsynaptic origin of the norepinephrine metabolites formed during transmitter release elicited by nerve stimulation. J. Pharmacol. exp. Ther. 183, 90–102 (1972)
Levin, J. A.: Metabolism of 3H-norepinephrine by the adventitia and media of rabbit aorta. Vth. Int. Congr. Pharmacol., p. 139, 1972
Levitt, M., Spector, S., Sjoerdsma, A., Udenfriend, S.: Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J. Pharmacol. exp. Ther. 148, 1–8 (1965)
Luchelli-Fortis, M. A., Langer, S. Z.: Reserpine-induced depletion of the norepinephrine stores: is it a reliable criterion for the classification of sympathomimetic amines? J. Pharmacol. exp. Ther. (in press)
Nagatsu, T., Levitt, M., Udenfriend, S.: Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. biol. Chem. 239, 2910–2917 (1964)
Nagatsu, T., Mizutani, K., Nagatsu, I., Matsuura, S., Sugimoto, T.: Pteridines as cofactor or inhibitor of tyrosine hydroxylase. Biochem. Pharmacol. 21, 1945–1953 (1972)
Schott, H. F., Clark, W. G.: Dopa decarboxylase inhibition through the interaction of coenzyme and substrate. J. biol. Chem. 196, 449–462 (1952)
Snedecor, G. W., Cochran, W. G.: Statistical methods. Sixth Edit. Ames. Iowa: The Iowa State University Press 1967
Spector, S., Gordon, R., Sjoerdsma, A., Udenfriend, S.: End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. Molec. Pharmacol. 3, 549–555 (1967)
Tarlov Suzanne, R., Langer, S. Z.: The fate of 3H-norepinephrine released from isolated atria and vas deferens: effect of field stimulation. J. Pharmacol. exp. Ther. 179, 186–197 (1971)
Udenfriend, S., Zaltzman-Nirenberg, P., Nagatsu, T.: Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem. Pharmacol. 14, 837–845 (1965)
Waymire, J. C., Bjur, R., Weiner, N.: Assay of tyrosine hydroxylase by coupled decarboxylation of dopa formed from 1-14C-l-tyrosine. Analyt. Biochem. 43, 588–600 (1971)
Weiner, N.: Regulation of norepinephrine biosynthesis. Ann. Rev. Pharmacol. 10, 273–290 (1970)
Weiner, N., Cloutier, G., Bjur, R., Pfeffer, R. I.: Modification of norepinephrine synthesis in intact tissue by drugs and during short term adrenergic nerve stimulation. Pharmacol. Rev. 29, 203–221 (1972)
Weiner, N., Rabadjija, M.: The effect of nerve stimulation on the synthesis and metabolism of norepinephrine in the isolated guinea-pig hypogastric nerve vas deferens preparation. J. Pharmacol. exp. Ther. 160, 61–71 (1968)
Weiner, N., Selvaratnam, I.: The effect of tyramine on the synthesis of norepinephrine. J. Pharmacol. exp. Ther. 161, 21–33 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubio, M.C., Langer, S.Z. Effects of the noradrenaline metabolites on tyrosine hydroxylase activity in guinea-pig atria. Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 315–330 (1973). https://doi.org/10.1007/BF00501354
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00501354